Page last updated: 2024-09-03

astragaloside a and Cardiovascular Diseases

astragaloside a has been researched along with Cardiovascular Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Guo, J; He, Q; Jiang, F; Lu, X; Meng, P; Yang, R; Yang, T1
Cheng, Z; Feng, J; Guo, H; Li, P; Liu, B; Qin, W; Shao, S; Wan, M; Xu, Z; Xue, W; Zhang, Y; Zhou, H1
Chen, HW; Li, J; Tan, YQ1
Qi, R; Tuerdi, N; Wan, Y; Wang, Y; Xu, L; Ye, M1
Cao, Z; Ding, H; Li, F; Rui, Y; Tao, L; Yang, P; Zhang, W; Zhao, J1

Reviews

3 review(s) available for astragaloside a and Cardiovascular Diseases

ArticleYear
Molecular Mechanism of Astragaloside IV in Improving Endothelial Dysfunction of Cardiovascular Diseases Mediated by Oxidative Stress.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Animals; Cardiovascular Diseases; Endothelium, Vascular; Humans; Oxidative Stress; Saponins; Triterpenes

2021
Recent pharmacological advances in the treatment of cardiovascular events with Astragaloside IV.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 168

    Topics: Cardiovascular Diseases; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Saponins; Triterpenes

2023
Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases.
    Drug design, development and therapy, 2020, Volume: 14

    Topics: Astragalus propinquus; Cardiovascular Diseases; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Molecular Conformation; Saponins; Triterpenes

2020

Other Studies

2 other study(ies) available for astragaloside a and Cardiovascular Diseases

ArticleYear
Preventive effects of astragaloside IV and its active sapogenin cycloastragenol on cardiac fibrosis of mice by inhibiting the NLRP3 inflammasome.
    European journal of pharmacology, 2018, Aug-15, Volume: 833

    Topics: Animals; Cardiovascular Diseases; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Fibroblasts; Fibrosis; Heart; Humans; Inflammasomes; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Sapogenins; Saponins; Triterpenes

2018
Therapeutic effects of astragaloside IV on myocardial injuries: multi-target identification and network analysis.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Binding Sites; Cardiovascular Diseases; Computational Biology; Cytoprotection; Doxorubicin; Drug Approval; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Myocytes, Cardiac; Protein Conformation; Protein Interaction Mapping; Reproducibility of Results; Saponins; Signal Transduction; Triterpenes; United States; United States Food and Drug Administration

2012